Clinical manifestations of dengue hemorrhagic fever in Puerto Rico, 1990-1991

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 1, Issue 5, 1997, Pages 381-388

  Rigau Pérez, José G ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLEEDING; CAPILLARY PERMEABILITY; CHILD; DENGUE; FEMALE; FEVER; HEMOCONCENTRATION; HOSPITALIZATION; HUMAN; HYPOALBUMINEMIA; INFANT; MAJOR CLINICAL STUDY; MALE; PUERTO RICO; THROMBOCYTOPENIA;

EID: 0030776446     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49891997000500007     Document Type: Article

References (57)

1. Institute of Medicine. Emerging infections: microbial threats to health in the United States. Washington, DC: National Academy Press; 1992.
2. Centers for Disease Control and Prevention. Addressing emerging infectious disease threats: a prevention strategy for the United States. Atlanta: U.S. Department of Health and Human Services, Public Health Service; 1994.
3. Halstead SB. The XXth century dengue pandemic: need for surveillance and research. World Health Stat Q 1992;45:292-298.
4. Nimmannitya S. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 1987; 18:392-397.
5. Sumarmo, Wuryadi S, Gubler DJ. Clinical observations on hospitalized patients with virologically confirmed dengue hemorrhagic fever in Jakarta, Indonesia 1975-1983. Paediatr Indones 1986;26:137-151.
6. Chin CK. Outpatient management of dengue infection in the University Hospital, Kuala Lumpur. Malays J Pathol 1993;15:21-23.
7. Rohde JE. Clinical management of severe dengue. Trop Doct 1978;8:54-61.
8. Tassniyom S, Vasanawathana V, Chirawatkul A, Rojanasuphot S. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics 1993;92:111-115.
9. Lum LCS. Management of dengue haemorrhagic fever/dengue shock syndrome. Malays J Pathol 1993;15:29-33.
10. Yong BH. Critical care aspects of dengue haemorrhagic fever/dengue shock syndrome. Malays J Pathol 1993;15:35-39.
11. Sumarmo, Wulur H, Jahja E, Gubler DJ, Suharyono W, Sorensen K. Clinical observations on virologically confirmed fatal dengue infections in Jakarta, Indonesia. Bull World Health Organ 1983;61:693-701.
12. López Correa RH, Cline BL, Ramírez-Ronda C, Bermúdez R, Sather GE, Kuno G. Dengue fever with hemorrhagic manifestations: a report of three cases from Puerto Rico. Am J Trop Med Hyg 1978;27:1216-1224.
13. Woodall JP, López-Correa RH, Sather GE, Moore CG. The absence of epidemic dengue hemorrhagic fever from the Americas. In: Hotta S, ed. Dengue hemorrhagic fever 1981: proceedings of the First International Center for Medical Research Seminar 1980, Nov 21-22, Kobe, Japan. Kobe: ICMR; 95-106.
14. Álvarez ME, Ramírez-Ronda CH. Dengue and hepatic failure. Am J Med 1985;79:670-674.
15. Gubler DJ. Dengue and dengue hemorrhagic fever in the Americas. P R Health Sci J 1987; 6:107-111.
16. Ramírez-Ronda CH. Dengue in Puerto Rico: clinical manifestations and management from the 1960s to 1987. P R Health Sci J 1987;6: 113-118.
17. Pan American Health Organization. Dengue in the Americas: an update. Epidemiol Bull (PAHO) 1993;14:1-3.
18. Rigau-Pérez JG, Gubler DJ, Vorndam AV, Clark GG. Dengue surveillance: United States, 1986-1992. In: Centers for Disease Control and Prevention. CDC surveillance summaries. 22 July 1994;43(No. SS-2):7-19.
19. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, and control. Geneva: WHO; 1986:12-14.
20. Gubler DJ. Surveillance for dengue and dengue hemorrhagic fever. Bull Pan Am Health Organ 1989;23:397-404.
21. Gubler DJ, Casta-Vélez A. A program for prevention and control of epidemic dengue and dengue hemorrhagic fever in Puerto Rico and the U.S. Virgin Islands. Bull Pan Am Health Organ 1991;25:237-247.
22. Jordan CD, Flood JG, Laposata M, Lewandrowski KB. Normal reference laboratory values. N Engl J Med 1993;327:718-724.
23. Anonymous. JAMA instructions for authors. JAMA 1995;273:27-34.
24. Yager HM, Harrington JT. Urinalysis and urinary electrolytes. In: Jacobson HR, Striker GE, Klahr S, eds. The principles and practice of nephrology. Philadelphia: Decker; 1991:171.
25. Rosen L, Gubler DJ. The use of mosquitoes to detect and propagate dengue viruses. Am J Trop Med Hyg 1974;23:1153-1160.
26. Gubler DJ, Kuno G, Sather GE, Vélez M, Oliver A. Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. Am J Trop Med Hyg 1984;33: 158-165.
27. Kuno G, Gubler DJ, Vélez M, Oliver A. Comparative sensitivity of three mosquito cell lines for isolation of dengue viruses. Bull World Health Organ 1985;63:279-286.
28. Burke DS, Nisalak A, Ussery MA. Antibody capture immunoassay detection of Japanese encephalitis virus immunoglobulin M and G antibodies in cerebrospinal fluid. J Clin Microbiol 1982;15:1034-1042.
29. Gubler DJ, Sather GE. Laboratory diagnosis of dengue and dengue hemorrhagic fever. In: Fonseca da Cunha F, ed. Simposio Internacional sobre Febre Amarela e Dengue, 1988, Rio de Janeiro: Fundação Oswaldo Cruz/Bio-Manguinhos; 1990:291-322.
30. Kuno G, Gómez I, Gubler DJ. Detecting artificial anti-dengue IgM immune complexes using an enzyme-linked immunosorbent assay. Am J Trop Med Hyg 1987;36:153-159.
31. Chungue E, Marché G, Plichart R, Boutin JP, Roux J. Comparison of immunoglobulin G enzyme-linked immunosorbent assay (IgG-ELISA) and haemagglutination inhibition (HI) test for the detection of dengue antibodies: prevalence of dengue IgG-ELISA antibodies in Tahiti. Trans R Soc Trop Med Hyg 1989;83:708-711.
32. Clarke DH, Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958;7:561-573.
33. Hall WC, Crowell TP, Watts DM, Barros VL, Kruger H, Pinheiro F, et al. Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis. Am J Trop Med Hyg 1991-45:408-417.
34. Gubler DJ, Suharyono W, Lubis I, Eram S, Sulianti Saroso J. Epidemic dengue haemorrhagic fever in rural Indonesia: I. virological and epidemiological studies. Am J Trop Med Hyg 1979;28:701-710.
35. Centers for Disease Control. Case definitions for public health surveillance. MMWR 1990; 39:RR-13, 10-11.
36. Lewis JG, Chang G-J, Lanciotti RS, Kinney RK, Mayer LW, Trent DW. Phylogenetic relationships of dengue-2 viruses. Virology 1993; 197:216-224.
37. Nimmannitya S, Halstead SB, Cohen SN, Margiotta MR. Dengue and chikungunya virus infection in man in Thailand, 1962-64: I. observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg 1969; 18:954-971.
38. Hayes CG, Manaloto CR, Gonzales A, Ranoa CP. Dengue infections in the Philippines: clinical and virological findings in 517 hospitalized patients. Am J Trop Med Hyg 1988;39: 110-116.
39. Qiu F-X, Gubler DJ, Liu J-C, Chen Q-Q. Dengue in China: a clinical review. Bull World Health Organ 1993;71:349-359.
40. Guzmán MG, Kourí GP, Bravo J, et al. Dengue haemorrhagic fever in Cuba: II. clinical investigations. Trans R Soc Trop Med Hyg 1984;78: 239-241.
41. Rosso F, Restrepo de Meza MT, Alzate A, Muñoz J, Moreno CH. Dengue hemorrágico en el Hospital Universitario del Valle, 1990-1992. Colombia Med 1994;25:10-14.
42. Zagne SMO, Alves VGF, Nogueira RMR, Miagostovich MP, Lampe E, Tavares W. Dengue haemorrhagic fever in the state of Rio de Janeiro, Brazil: a study of 56 confirmed cases. Trans R Soc Trop Med Hyg 1994;88:677-679.
43. Moreau J-P, Rosen L, Saugrain J, Lagraulet J. An epidemic of dengue on Tahiti associated with hemorrhagic manifestations. Am J Trop Med Hyg 1973;22:237-241.
44. Dietz VJ, Gubler DJ, Ortiz S, et al. The 1986 dengue and dengue hemorrhagic fever outbreak in Puerto Rico: epidemiologic and clinical observations. P R Health Sci J 1996;15: 201-210.
45. Munir M, Husada T, Mustadjab I. Dengue haemorrhagic fever: a problem of clinical diagnosis and proposal for using a scoring system. Paediatr Indones 1982;22:11-22.
46. Srivastava VK, Suri S, Bhasin A, Srivastava L, Bharadwaj M. An epidemic of dengue haemorrhagic fever and dengue shock syndrome in Delhi: a clinical study. Ann Trop Paediatr 1990;10:329-334.
47. Eram S, Setyabudi Y, Sadono TI, Sutrisno DS, Gubler DJ, Sulianti Saroso J. Epidemic dengue hemorrhagic fever in rural Indonesia: II. clinical studies. Am J Trop Med Hyg 1979;28: 711-716.
48. Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF. Liver biochemical tests and dengue fever. Am J Trop Med Hyg 1992; 47:265-270.
49. García S, Morales R, Hunter RF. Dengue fever with thrombocytopenia: studies towards defining vulnerability of bleeding. Bol Asoc Med P R 1995;87:2-7.
50. Innis BL, Myint KSA, Nisalak A, Ishak KG, Nimmannitya S, Laohapand T, et al. Acute liver failure is one important cause of fatal dengue infection. Southeast Asian J Trop Med Public Health 1990;21:695-696.
51. Lum LCS, Lam SK, George R, Devi S. Fulminant hepatitis in dengue infection. Southeast Asian J Trop Med Public Health 1993;24: 467-471.
52. Rajajee S, Mukundan D. Neurological manifestations in dengue hemorrhagic fever. Indian Pediatr 1994;31:688-690.
53. College of American Pathologists. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. JAMA 1994;271: 777-781.
54. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988;239: 476-481.
55. Kouri GP, Guzmán MG, Bravo JR, Triana C. Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull World Health Organ 1989;87:375-380.
56. Communicable Diseases Program, PAHO. Dengue hemorrhagic fever in Venezuela. Epidemiol Bull (PAHO) 1990;11(2):7-9.
57. Nathin MA, Harun SR, Sumarmo. Dengue haemorrhagic fever and Japanese B encephalitis in Indonesia. Southeast Asian J Trop Med Public Health 1988;19:475-481.